Alternatively spliced isoforms of fibronectin in immune-mediated glomerulosclerosis: The role of TGFβ and IL-4

Journal of Pathology

Volumn 204, Issue 3, 2004, Pages 248-257

  Baelde, Hans J ^a   Eikmans, Michael ^a   van Vliet, Anita I ^a   Bergijk, Eline C ^a   de Heer, Emile ^a   Bruijin, Jan A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

GBM; Thy1; Alternative splicing; CSS; Fibronectin; Glomerulonephritis; Glomerulosclerosis; GvHD; IL 4; TGF

Indexed keywords

COLLAGEN; FIBRONECTIN; INTERLEUKIN 4; ISOPROTEIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL INCLUSION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GLOMERULOSCLEROSIS; GRAFT VERSUS HOST REACTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MESANGIUM CELL; MOUSE; NEPHRITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; RNA ANALYSIS; SERUM SICKNESS; TH2 CELL;

ALTERNATIVE SPLICING; ANIMALS; CELLS, CULTURED; CHRONIC DISEASE; FEMALE; FIBRONECTINS; GLOMERULONEPHRITIS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-4; KIDNEY DISEASES; KIDNEY GLOMERULUS; MICE; MICE, INBRED C57BL; PROTEIN ISOFORMS; RATS; RATS, INBRED LEW; RATS, WISTAR; RNA, MESSENGER; SCLEROSIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 7244232715     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1653     Document Type: Article

References (50)

1. Van Vliet A, Baelde HJ, Vleming LJ, De Heer E, Bruijn JA. Distribution of fibronectin isoforms in human renal disease. J Pathol 2001; 193: 256-262.
2. Assad L, Schwartz MM, Virtanen I, Gould VE. Immunolocalization of tenascin and cellular fibronectins in diverse glomerulopathies. Virchows Arch B Cell Pathol Incl Mol Pathol 1993; 63: 307-316.
3. Abrass CK, Adcox MJ, Raugi GJ. Aging-associated changes in renal extracellular matrix. Am J Pathol 1995; 146: 742-752.
4. Vleming LJ, Baelde JJ, Westendorp RGJ, et al. The glomerular deposition of PAS positive material correlates with renal function in human kidney diseases. Clin Nephrol 1997; 47: 158-167.
5. Bergijk EC, Munaut C, Baelde JJ, et al. A histological study of the extracellular matrix during the development of glomerulosclerosis in murine chronic graft-versus-host disease. Am J Pathol 1992; 140: 1147-1156.
6. Van Vliet AI, van Alderwegen IE, Baelde HJ, De Heer E, Bruijn JA. Fibronectin accumulation in glomerulosclerotic lesions: self-assembly sites and the heparin II binding domain. Kidney Int 2002; 61: 481-489.
7. Ruoslahti E. Fibronectin and its receptors. Annu Rev Biochem 1988; 57: 375-413.
8. Oyama F, Murata Y, Suganuma N, Kimura T, Titani K, Sekiguchi K. Patterns of alternative splicing of fibronectin pre-mRNA in human adult and fetal tissues. Biochemistry 1989; 28: 1428-1434.
9. Ffrench-Constant C, Van De WL, Dvorak HF, Hynes RO. Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol 1989; 109: 903-914.
10. Kornblihtt AR, Umezawa K, Vibe-Pedersen K, Baralle FE. Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. EMBO J 1985; 4: 1755-1759.
11. Schwarzbauer JE, Patel RS, Fonda D, Hynes RO. Multiple sites of alternative splicing of the rat fibronectin gene transcript. EMBO J 1987; 6: 2573-2580.
12. Pagani F, Zagato L, Vergani C, Casari G, Sidoli A, Baralle FE. Tissue-specific splicing pattern of fibronectin messenger RNA precursor during development and aging in rat. J Cell Biol 1991; 113: 1223-1229.
13. Magnuson VL, Young M, Schattenberg DG, et al. The alternative splicing of fibronectin pre-mRNA is altered during aging and in response to growth factors. J Biol Chem 1991; 266: 14 654-14 662.
14. Ffrench-Constant C, Hynes RO. Alternative splicing of fibronectin is temporally and spatially regulated in the chicken embryo. Development 1989; 106: 375-388.
15. Brown LF, Dubin D, Lavigne L, Logan B, Dvorak HF, Van De WL. Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing. Am J Pathol 1993; 142: 793-801.
16. Nickeleit V, Zagachin L, Nishikawa K, Peters JH, Hynes RO, Colvin RB. Embryonic fibronectin isoforms are synthesized in crescents in experimental autoimmune glomerulonephritis. Am J Pathol 1995; 147: 965-978.
17. Barnes JL, Torres ES, Mitchell RJ, Peters JH. Expression of alternatively spliced fibronectin variants during remodeling in proliferative glomerulonephritis. Am J Pathol 1995; 147: 1361-1371.
18. Alonso J, Gómez-Chiarri M, Ortíz A, et al. Glomerular up-regulation of EIIIA and V120 fibronectin isoforms in proliferative immune complex nephritis. Kidney Int 1996; 50: 908-919.
19. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 1990; 346: 371-374.
20. Viedt C, Burger A, Hansch GM. Fibronectin synthesis in tubular epithelial cells: up-regulation of the EDA splice variant by transforming growth factor beta. Kidney Int 1995; 48: 1810-1817.
21. Balza E, Borsi L, Allemanni G, Zardi L. Transforming growth factor β regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. FEBS Lett 1988; 228: 42-44.
22. Furusu A, Miyazaki M, Koji T, et al. Involvement of IL-4 in human glomerulonephritis: an in situ hybridization study of IL-4 mRNA and IL-4 receptor mRNA. J Am Soc Nephrol 1997; 8: 730-741.
23. de Wit D, van Mechelen M, Zanin C, et al. Preferential activation of Th2 cells in chronic graft-versus-host reaction. J Immunol 1993; 150: 361-366.
24. Bagchus WM, Hoedemaeker PJ, Rozing J, Bakker WW. Glomerulonephritis induced by monoclonal anti-Thy 1.1 antibodies: a sequential histological and ultrastructural study in the rat. Lab Invest 1986; 55: 680-687.
25. Bergijk EC, Baelde HJ, De Heer E, Killen PD, Bruijn JA. Role of the extracellular matrix in the development of glomerulosclerosis in experimental chronic serum sickness. Exp Nephrol 1995; 3: 338-347.
26. Hogendoorn PCW, Bruijn JA, Gelok EWA, Van den Broek LJ, Fleuren GJ. Development of progressive glomerulosclerosis in experimental chronic serum sickness. Nephrol Dial Transplant 1990; 5: 100-109.
27. Sehrijver G, Bogman MJ, Assmann KJM, et al. Anti-GBM nephritis in the mouse: role of granulocytes in the heterologous phase. Kidney Int 1990; 38: 86-95.
28. Bruijn JA, Van Elven EH, Hogendoorn PCW, Corver WE, Hoedemaeker PJ, Fleuren GJ. Murine chronic graft-versus-host disease as a model for human lupus nephritis. Am J Pathol 1988; 130: 639-641.
29. Bowman C, Peters DK, Lockwood CM. Anti-glomerular basement membrane autoantibodies in the Brown Norway rat: detection by a solid-phase radioimmunoassay. J Immunol Methods 1983; 61: 325-333.
30. Baelde JJ, Bergijk EC, Hoedemaeker PJ, De Heer E, Bruijn JA. Optimal method for RNA extraction from mouse glomeruli. Nephrol Dial Transplant 1994; 9: 304-308.
31. Bergijk EC, Baelde HJ, Kootstra CJ, De Heer E, Killen PD, Bruijn JA. Cloning of the mouse fibronectin V-region and variation of its splicing pattern in experimental immune complex glomerulonephritis. J Pathol 1996; 178: 462-468.
32. De Heer E, Pas O, Prins F, et al. The major TGF-β1 synthesizing cells in rats with anti-Thy-1 neprhitits are intrinsic mesangial cells. (abstract) J Am Soc Nephrol 1993; 4: 946.
33. Van Vliet AI, van Alderwegen IE, Baelde HJ, et al. Differential expression of collagen type IV alpha-chains in the tubulointerstitial compartment in experimental chronic serum sickness nephritis. J Pathol 1999; 189: 279-287.
34. Eikmans M, Baelde HJ, De Heer E, Bruijn JA. Effect of age and biopsy site on extracellular matrix mRNA and protein levels in human kidney biopsies. Kidney Int 2001; 60: 974-981.
35. Eikmans M, Baelde HJ, De Heer E, Bruijn JA. Processing renal biopsies for diagnostic mRNA quantification: improvement of RNA extraction and storage conditions. J Am Soc Nephrol 2000; 11: 868-873.
36. Aben JA, Hoogervorst DA, Paul LC, et al. Genes expressed by the kidney, but not by bone marrow-derived cells, underlie the genetic predisposition to progressive glomerulosclerosis after mesangial injury. J Am Soc Nephrol 2003; 14: 2264-2270.
37. Tang WW, Feng L, Loskutoff DJ, Wilson CB. Glomerular extracellular matrix accumulation in experimental anti-GBM Ab glomerulonephritis. Nephron 2000; 84: 40-48.
38. Datta PK, Reddy RS, Lianos EA. Effects of all-trans-retinoic acid (atRA) on inducible nitric oxide synthase (iNOS) activity and transforming growth factor beta-1 production in experimental anti-GBM antibody-mediated glomerulonephritis. Inflammation 2001; 25: 351-359.
39. Alonso J, Mampaso F, Martin A, Palacios I, Egido J. Changes in the pattern of fibronectin mRNA alternative splicing in acute experimental mesangioproliferative nephritis. Lab Invest 1999; 79: 185-194.
40. Bürger A, Wagner C, Viedt C, Reis B, Hug F, Hänsch GM. Fibronectin synthesis by human tubular epithelial cells in culture: effects of PDGF and TGF-β on synthesis and splicing. Kidney Int 1998; 54: 407-415.
41. Van der Velde-Zimmermann D, Verdaasdonk MAM, Rademakers LHPM, De Weger RA, Van den Tweel JG, Joling P. Fibronectin distribution in human bone marrow stroma: matrix assembly and tumor cell adhesion via α5β1 integrin. Exp Cell Res 1997; 230: 111-120.
42. Kanamaru Y, Nakao A, Mamura M, et al. Blockade of TGF-beta signaling in T cells prevents the development of experimental glomerulonephritis. J Immunol 2001; 166: 2818-2823.
43. Cook HT, Singh SJ, Wembridge DE, Smith J, Tam FW, Pusey CD. Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats. Kidney Int 1999; 55: 1319-1326.
44. Ruger BM, Hasan Q, Erb KJ, Davis PF. Progression of renal disease in interleukin-4 transgenic mice: involvement of transforming growth factor-beta. Int J Exp Pathol 1999; 80: 113-123.
45. Bergijk EC, Baelde HJ, De Heer E, Killen PD, Bruijn JA. Specific accumulation of exogenous fibronectin in experimental glomerulosclerosis. J Pathol 1995; 176: 191-199.
46. Doucet C, Brouty-Boye D, Pottin-Clemenceau C, Jasmin C, Canonica GW, Azzarone B. IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts. Int Immunol 1998; 10: 1421-1433.
47. Ruger BM, Erb KJ, He Y, Lane JM, Davis PF, Hasan Q. Interleukin-4 transgenic mice develop glomerulosclerosis independent of immunoglobulin deposition. Eur J Immunol 2000; 30: 2698-2703.
48. Buttner C, Skupin A, Rieber EP. Transcriptional activation of the type I collagen genes COL1A1 and COL1A2 in fibroblasts by interleukin-4: analysis of the functional collagen promoter sequences. J Cell Physiol 2004; 198: 248-258.
49. Singh RR, Saxena V, Zang S, et al. Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis. J Immunol 2003; 170: 4818-4825.
50. De Albuquerque DA, Saxena V, Adams DE, et al. An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis. Kidney Int 2004; 65: 846-859.